Select Page

ERBITUX® (cetuximab) injection, for intravenous use. Initial U.S. Approval: 2004

ERBITUX® (cetuximab) injection, for intravenous use. Initial U.S. Approval: 2004

ERBITUX® (cetuximab) injection is a Anti Cancer medicine. ERBITUX® (cetuximab) injection is used to treat Head and Neck Cancer, Colorectal Cancer.

INDICATIONS AND USAGE
ERBITUX® is an epidermal growth factor receptor (EGFR) antagonist indicated for treatment of:
Head and Neck Cancer
• Locally or regionally advanced squamous cell carcinoma of the head and neck in combination with radiation therapy.
• Recurrent locoregional disease or metastatic squamous cell carcinoma of the head and neck in combination with platinumbased therapy with fluorouracil.
• Recurrent or metastatic squamous cell carcinoma of the head and neck progressing after platinum-based therapy.
Colorectal Cancer
K-Ras wild-type, EGFR-expressing, metastatic colorectal cancer as determined by an FDA-approved test
• in combination with FOLFIRI for first-line treatment,
• in combination with irinotecan in patients who are refractory to irinotecan-based chemotherapy,
• as a single agent in patients who have failed oxaliplatin- and irinotecan-based chemotherapy or who are intolerant to irinotecan.
DOSAGE FORMS & STRENGTHS
Injection: 100 mg/50 mL (2 mg/mL) or 200 mg/100 mL (2 mg/mL) in a single-dose vial.
Manufactured By: Eli Lilly
Prescribing Information URL: Click Here

Procedure to buy ERBITUX® (cetuximab) injection?
To buy ERBITUX® (cetuximab) injection, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

What is cetuximab?

Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Eli Lilly and Co. and outside those countries by the drug company Merck KGaA. In Japan, Merck KGaA, Bristol-Myers Squibb and Eli Lilly have a co-distribution.

In July 2009, the U.S. Food and Drug Administration (FDA) approved cetuximab (Erbitux) for treatment of colon cancer with wild-type KRAS, since it had little or no effect in colorectal tumors harboring a KRAS mutation (this also applied to the EGFR antibody panitumumab). Cetuximab is approved for K-RAS wild-type metastatic colorectal cancer in the US & Canada (Eli Lilly). In Europe and the rest of the world (Merck KGaA), cetuximab is approved for RAS wild-type metastatic colorectal cancer.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

ERBITUX® (cetuximab) injection in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ERBITUX® (cetuximab) injection in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ERBITUX® (cetuximab) injection in North America – Mexico.
ERBITUX® (cetuximab) injection in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ERBITUX® (cetuximab) injection in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ERBITUX® (cetuximab) injection in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ERBITUX® (cetuximab) injection in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ERBITUX® (cetuximab) injection in Australia and New Zealand.

For Indian Patient

Ani-Cancer ERBITUX® (cetuximab) injection are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

ERBITUX® (cetuximab) injection can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “ERBITUX® (cetuximab) injection, for intravenous use. Initial U.S. Approval: 2004”

Your email address will not be published.

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.